| value |
{"aggregator_url":"https://www.nasdaq. {"aggregator_url":"https://www.nasdaq.com/articles/oscr-crosses-above-average-analyst-target","as_of":"2026-04-16T12:17:43.961520+00:00","canonical_url":"https://www.nasdaq.com/articles/oscr-crosses-above-average-analyst-target","enrichment":{"aggregator_url":"https://www.nasdaq.com/articles/oscr-crosses-above-average-analyst-target","article_chars":2186,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_ee7557e6d8cf5799","canonical_host":"nasdaq.com","canonical_is_aggregator":false,"canonical_url":"https://www.nasdaq.com/articles/oscr-crosses-above-average-analyst-target","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-16T12:25:06.096771+00:00","extraction_method":"trafilatura","fetched_description":"In recent trading, shares of Oscar Health Inc (Symbol: OSCR) have crossed above the average analyst 12-month target price of $7.54, changing hands for $7.85/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valua","fetched_title":"OSCR Crosses Above Average Analyst Target | Nasdaq","final_url":"https://www.nasdaq.com/articles/oscr-crosses-above-average-analyst-target","html_truncated":false,"paywall_likely":false,"publisher_domain":"nasdaq.com","publisher_resolution":"canonical_url","requested_url":"https://www.nasdaq.com/articles/oscr-crosses-above-average-analyst-target","source_event_id":"evt_56c58329142e","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"fp":"eb244ccbf104527f","kind":"unusual_volume","published_at":"2026-04-16T11:03:59+00:00","publisher_domain":"nasdaq.com","signal_understanding":{"analysis_basis":"article","claim_confidence":0.62,"dates_mentioned":[],"entities":[{"asset_class":"equity","name":"Oscar Health Inc","relevance":"high","symbol":"OSCR","type":"company"}],"event_type":"price_action","information_gaps":["No volume data is provided (baseline volume, current volume, or volume ratio vs average are missing), so the \u201cdiscovery_unusual_volume_delta\u201d cannot be confirmed from the text.","The headline mentions a different target/price ($15.40 and $15.59) than the cleaned article text ($7.54 and $7.85); the discrepancy is unresolved.","No explicit catalyst is described in the provided text beyond a general discussion of analyst reactions depending on fundamental developments.","No confirmation from external news is provided; the text appears to be an analyst-target/price comparison article using Zacks data."],"key_facts":["Oscar Health Inc (OSCR) is stated to have crossed above the average analyst 12-month target price.","The average analyst 12-month target cited is $7.54/share.","The reported recent trading price is $7.85/share.","The article references multiple analyst targets within Zacks coverage and mentions a standard deviation of $2.933 for those targets.","The article frames potential analyst reactions as either downgrading on valuation or raising the target if fundamentals improve."],"numeric_claims":[{"label":"average_analyst_12m_target","value":"$7.54/share"},{"label":"recent_trading_price","value":"$7.85/share"},{"label":"standard_deviation_of_targets","value":"$2.933"}],"primary_claim":"OSCR recently traded at $7.85/share, crossing above the average analyst 12-month target price of $7.54/share.","relevance_score":0.45,"sentiment":"neutral","source_quality":"medium","summary":"The signal claims Oscar Health (OSCR) has traded above the average analyst 12-month target price, with the stock at $7.85 versus an average target of $7.54. The provided text does not include any volume metrics, so the \u201cunusual volume delta\u201d aspect is not evidenced here.","topics":["analyst price targets","valuation","stock price crossing analyst target"]},"source":"Nasdaq Markets","source_domain":"nasdaq.com","summary":"In recent trading, shares of Oscar Health Inc (Symbol: OSCR) have crossed above the average analyst 12-month target price of $15.40, changing hands for $15.59/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on val","tickers":[],"title":"OSCR Crosses Above Average Analyst Target","url":"https://www.nasdaq.com/articles/oscr-crosses-above-average-analyst-target"}... |